Cell Therapy in Chagas Disease

Chagas disease which is caused by the parasite Trypanosoma cruzi is an important cause of cardiomyopathy in Latin America. In later stages chagasic cardiomyopathy is associated with congestive heart failure which is often refractory to medical therapy. In these individuals heart transplantation has...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonio C. Campos de Carvalho, Regina C. S. Goldenberg, Linda A. Jelicks, Milena B. P. Soares, Ricardo Ribeiro dos Santos, David C. Spray, Herbert B. Tanowitz
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Interdisciplinary Perspectives on Infectious Diseases
Online Access:http://dx.doi.org/10.1155/2009/484358
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849685143323672576
author Antonio C. Campos de Carvalho
Regina C. S. Goldenberg
Linda A. Jelicks
Milena B. P. Soares
Ricardo Ribeiro dos Santos
David C. Spray
Herbert B. Tanowitz
author_facet Antonio C. Campos de Carvalho
Regina C. S. Goldenberg
Linda A. Jelicks
Milena B. P. Soares
Ricardo Ribeiro dos Santos
David C. Spray
Herbert B. Tanowitz
author_sort Antonio C. Campos de Carvalho
collection DOAJ
description Chagas disease which is caused by the parasite Trypanosoma cruzi is an important cause of cardiomyopathy in Latin America. In later stages chagasic cardiomyopathy is associated with congestive heart failure which is often refractory to medical therapy. In these individuals heart transplantation has been attempted. However, this procedure is fraught with many problems attributable to the surgery and the postsurgical administration of immunosuppressive drugs. Studies in mice suggest that the transplantation of bone-marrow-derived cells ameliorates the inflammation and fibrosis in the heart associated with this infection. Cardiac magnetic resonance imaging reveals that bone marrow transplantation ameliorates the infection induced right ventricular enlargement. On the basis of these animal studies the safety of autologous bone marrow transplantation has been assessed in patients with chagasic end-stage heart disease. The initial results are encouraging and more studies need to be performed.
format Article
id doaj-art-c31be53e42e44012b4ea3136aff95d14
institution DOAJ
issn 1687-708X
1687-7098
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Interdisciplinary Perspectives on Infectious Diseases
spelling doaj-art-c31be53e42e44012b4ea3136aff95d142025-08-20T03:23:15ZengWileyInterdisciplinary Perspectives on Infectious Diseases1687-708X1687-70982009-01-01200910.1155/2009/484358484358Cell Therapy in Chagas DiseaseAntonio C. Campos de Carvalho0Regina C. S. Goldenberg1Linda A. Jelicks2Milena B. P. Soares3Ricardo Ribeiro dos Santos4David C. Spray5Herbert B. Tanowitz6Instituto Nacional de Cardiologia, 22240-006 Rio de Janeiro, RJ, BrazilInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21941-590 Rio de Janeiro, RJ, BrazilDepartment of Physiology & Biophysics, Albert Einstein College of Medicine, Bronx, NY 10461, USACentro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz, 40296-70 Salvador, BA, BrazilCentro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz, 40296-70 Salvador, BA, BrazilDominick P. Purpura, Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USADepartment of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USAChagas disease which is caused by the parasite Trypanosoma cruzi is an important cause of cardiomyopathy in Latin America. In later stages chagasic cardiomyopathy is associated with congestive heart failure which is often refractory to medical therapy. In these individuals heart transplantation has been attempted. However, this procedure is fraught with many problems attributable to the surgery and the postsurgical administration of immunosuppressive drugs. Studies in mice suggest that the transplantation of bone-marrow-derived cells ameliorates the inflammation and fibrosis in the heart associated with this infection. Cardiac magnetic resonance imaging reveals that bone marrow transplantation ameliorates the infection induced right ventricular enlargement. On the basis of these animal studies the safety of autologous bone marrow transplantation has been assessed in patients with chagasic end-stage heart disease. The initial results are encouraging and more studies need to be performed.http://dx.doi.org/10.1155/2009/484358
spellingShingle Antonio C. Campos de Carvalho
Regina C. S. Goldenberg
Linda A. Jelicks
Milena B. P. Soares
Ricardo Ribeiro dos Santos
David C. Spray
Herbert B. Tanowitz
Cell Therapy in Chagas Disease
Interdisciplinary Perspectives on Infectious Diseases
title Cell Therapy in Chagas Disease
title_full Cell Therapy in Chagas Disease
title_fullStr Cell Therapy in Chagas Disease
title_full_unstemmed Cell Therapy in Chagas Disease
title_short Cell Therapy in Chagas Disease
title_sort cell therapy in chagas disease
url http://dx.doi.org/10.1155/2009/484358
work_keys_str_mv AT antonioccamposdecarvalho celltherapyinchagasdisease
AT reginacsgoldenberg celltherapyinchagasdisease
AT lindaajelicks celltherapyinchagasdisease
AT milenabpsoares celltherapyinchagasdisease
AT ricardoribeirodossantos celltherapyinchagasdisease
AT davidcspray celltherapyinchagasdisease
AT herbertbtanowitz celltherapyinchagasdisease